Use of L-acetylcarnitine for the treatment of AIDS
US5656628A · kind A · utility
2Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 27, 1994 |
| Grant date | Aug 12, 1997 |
| Priority date | — |
| Expiry date | Dec 27, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of L-acylcarnitine for the preparation of a drug and a technique for relieving the disease symptoms appearing in AIDS by administering an L-acylcarnitine. The invention furthermore relates to a drug for this purpose, characterized in content by L-acylcarnitine as active principle. The preferred L-acylcarnitine is L-acetylcarnitine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.